UBS Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Sell |
82,760
-91,081
| -52% | -$15.7M | ﹤0.01% | 2142 |
|
|
2025
Q1 | $27.1M | Sell |
173,841
-51,846
| -23% | -$8.08M | 0.01% | 1587 |
|
|
2024
Q4 | $31.1M | Buy |
225,687
+213,262
| +1,716% | +$29.4M | 0.01% | 1433 |
|
|
2024
Q3 | $1.86M | Sell |
12,425
-3,496
| -22% | -$522K | ﹤0.01% | 3097 |
|
|
2024
Q2 | $2.17M | Sell |
15,921
-11,834
| -43% | -$1.61M | ﹤0.01% | 2780 |
|
|
2024
Q1 | $4.2M | Sell |
27,755
-172
| -0.6% | -$26K | ﹤0.01% | 2355 |
|
|
2023
Q4 | $3.52M | Sell |
27,927
-15,304
| -35% | -$1.93M | ﹤0.01% | 2315 |
|
|
2023
Q3 | $4.05M | Sell |
43,231
-556
| -1% | -$52.1K | ﹤0.01% | 2012 |
|
|
2023
Q2 | $3.91M | Buy |
43,787
+40,416
| +1,199% | +$3.61M | ﹤0.01% | 2101 |
|
|
2023
Q1 | $361K | Buy |
3,371
+751
| +29% | +$80.5K | ﹤0.01% | 3930 |
|
|
2022
Q4 | $320K | Sell |
2,620
-6,273
| -71% | -$766K | ﹤0.01% | 4020 |
|
|
2022
Q3 | $918K | Buy |
8,893
+7,376
| +486% | +$761K | ﹤0.01% | 2913 |
|
|
2022
Q2 | $141K | Sell |
1,517
-3,864
| -72% | -$359K | ﹤0.01% | 4188 |
|
|
2022
Q1 | $631K | Sell |
5,381
-1,000
| -16% | -$117K | ﹤0.01% | 3599 |
|
|
2021
Q4 | $859K | Sell |
6,381
-3,491
| -35% | -$470K | ﹤0.01% | 3559 |
|
|
2021
Q3 | $1.57M | Sell |
9,872
-1,162
| -11% | -$185K | ﹤0.01% | 2926 |
|
|
2021
Q2 | $1.45M | Buy |
11,034
+7,976
| +261% | +$1.05M | ﹤0.01% | 2974 |
|
|
2021
Q1 | $394K | Sell |
3,058
-208
| -6% | -$26.8K | ﹤0.01% | 4096 |
|
|
2020
Q4 | $545K | Sell |
3,266
-4,127
| -56% | -$689K | ﹤0.01% | 3622 |
|
|
2020
Q3 | $1.14M | Buy |
7,393
+3,751
| +103% | +$579K | ﹤0.01% | 2832 |
|
|
2020
Q2 | $538K | Sell |
3,642
-7,041
| -66% | -$1.04M | ﹤0.01% | 3321 |
|
|
2020
Q1 | $1.2M | Sell |
10,683
-3,220
| -23% | -$363K | ﹤0.01% | 2531 |
|
|
2019
Q4 | $1.93M | Buy |
13,903
+6,969
| +101% | +$969K | ﹤0.01% | 2785 |
|
|
2019
Q3 | $668K | Buy |
6,934
+770
| +12% | +$74.2K | ﹤0.01% | 3499 |
|
|
2019
Q2 | $710K | Buy |
6,164
+648
| +12% | +$74.6K | ﹤0.01% | 3285 |
|
|
2019
Q1 | $650K | Sell |
5,516
-1,617
| -23% | -$191K | ﹤0.01% | 3198 |
|
|
2018
Q4 | $447K | Sell |
7,133
-7,172
| -50% | -$449K | ﹤0.01% | 3577 |
|
|
2018
Q3 | $1.01M | Buy |
14,305
+4,592
| +47% | +$326K | ﹤0.01% | 3136 |
|
|
2018
Q2 | $646K | Buy |
9,713
+2,979
| +44% | +$198K | ﹤0.01% | 3372 |
|
|
2018
Q1 | $440K | Buy |
6,734
+2,670
| +66% | +$174K | ﹤0.01% | 3544 |
|
|
2017
Q4 | $163K | Buy |
4,064
+3,549
| +689% | +$142K | ﹤0.01% | 4145 |
|
|
2017
Q3 | $19K | Buy |
+515
| New | +$19K | ﹤0.01% | 5582 |
|
|
2017
Q2 | – | Sell |
-959
| Closed | -$27K | – | 6671 |
|
|
2017
Q1 | $27K | Buy |
959
+759
| +380% | +$21.4K | ﹤0.01% | 5021 |
|
|
2016
Q4 | $4K | Sell |
200
-718
| -78% | -$14.4K | ﹤0.01% | 6331 |
|
|
2016
Q3 | $18K | Buy |
+918
| New | +$18K | ﹤0.01% | 5474 |
|
|
2016
Q2 | – | Sell |
-1,417
| Closed | -$26K | – | 6762 |
|
|
2016
Q1 | $26K | Buy |
1,417
+13
| +0.9% | +$239 | ﹤0.01% | 5181 |
|
|
2015
Q4 | $26K | Buy |
+1,404
| New | +$26K | ﹤0.01% | 5312 |
|
|
2015
Q3 | – | Sell |
-788
| Closed | -$14K | – | 6833 |
|
|
2015
Q2 | $14K | Sell |
788
-77
| -9% | -$1.37K | ﹤0.01% | 5748 |
|
|
2015
Q1 | $15K | Buy |
+865
| New | +$15K | ﹤0.01% | 5600 |
|